ResMed Inc.
No trades
No trades
Price target
231.150.000.00%
The 23 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 30 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of RMD is 173.10 EUR — it has increased by 2.46% in the past 24 hours. Watch ResMed Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange ResMed Inc. stocks are traded under the ticker RMD.
RMD stock has fallen by −1.73% compared to the previous week, the month change is a 2.70% rise, over the last year ResMed Inc. has showed a −25.29% decrease.
We've gathered analysts' opinions on ResMed Inc. future price: according to them, RMD price has a max estimate of 287.88 EUR and a min estimate of 158.23 EUR. Watch RMD chart and read a more detailed ResMed Inc. stock forecast: see what analysts think of ResMed Inc. and suggest that you do with its stocks.
RMD stock is 3.01% volatile and has beta coefficient of 0.28. Track ResMed Inc. stock price on the chart and check out the list of the most volatile stocks — is ResMed Inc. there?
Today ResMed Inc. has the market capitalization of 24.90 B, it has decreased by −0.28% over the last week.
Yes, you can track ResMed Inc. financials in yearly and quarterly reports right on TradingView.
ResMed Inc. is going to release the next earnings report on Aug 6, 2026. Keep track of upcoming events with our Earnings Calendar.
RMD earnings for the last quarter are 2.48 EUR per share, whereas the estimation was 2.42 EUR resulting in a 2.32% surprise. The estimated earnings for the next quarter are 2.53 EUR per share. See more details about ResMed Inc. earnings.
ResMed Inc. revenue for the last quarter amounts to 1.24 B EUR, despite the estimated figure of 1.23 B EUR. In the next quarter, revenue is expected to reach 1.28 B EUR.
RMD net income for the last quarter is 345.11 M EUR, while the quarter before that showed 334.26 M EUR of net income which accounts for 0.00% change. Track more ResMed Inc. financial stats to get the full picture.
Yes, RMD dividends are paid quarterly. The last dividend per share was 0.51 EUR. As of today, Dividend Yield (TTM)% is 1.25%. Tracking ResMed Inc. dividends might help you take more informed decisions.
ResMed Inc. dividend yield was 0.82% in 2025, and payout ratio reached 22.30%. The year before the numbers were 1.00% and 27.75% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 25, 2026, the company has 10.6 K employees. See our rating of the largest employees — is ResMed Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ResMed Inc. EBITDA is 1.89 B EUR, and current EBITDA margin is 37.37%. See more stats in ResMed Inc. financial statements.
Like other stocks, RMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ResMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ResMed Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ResMed Inc. stock shows the sell signal. See more of ResMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.